Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-15-000005
Filing Date
2015-01-05
Accepted
2015-01-05 20:01:14
Documents
2
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6189
2 hougenpoa.htm EX-24 3047
  Complete submission text file 0000874015-15-000005.txt   10727
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10070 BARNES CANYON ROAD C/O MOLECULAR BIOSYSTEMS INC SAN DIEGO CA 92121
Business Address
HOUGEN ELIZABETH L (Reporting) CIK: 0001074773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 15507719
SIC: 2835 In Vitro & In Vivo Diagnostic Substances